Validity and reliability of the newly translated Cornell Scale for Depression in Dementia (CSDD) applied to Greek outpatients with depression and depression and Alzheimer's disease by unknown
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Annals of General Psychiatry
Open AccessPoster presentation
Validity and reliability of the newly translated Cornell Scale for 
Depression in Dementia (CSDD) applied to Greek outpatients with 
depression and depression and Alzheimer's disease
Antonis Politis, Antonis Maillis, Olga Thomadaki, Maria Passa, 
Evaggelia Stamouli, Maria Kotrotsou*, Konstantinos Kontoaggellos and 
Constantinos Soldatos
Address: University of Athens, Eginition Hospital, Athens, Greece
* Corresponding author    
Background
Major depression affects about 25% of patients with
Alzheimer's disease (AD) and has serious adverse conse-
quences for patients and caregivers. Several scales have
been used to quantify depression in patients with demen-
tia. The two used most often were the Cornell Scale for
Depression in Dementia (CSDD) and the Hamilton
Depression Rating Scale (HDRS). Previously, for Greek
speaking patients, no rating scales of depressive symp-
toms of patients with dementia and Alzheimer's disease
(AD) have been available. None were developed or trans-
lated.
Materials and methods
To develop a Hellenic translation of the Cornell Scale for
Depression in Dementia (CSDD), to evaluate it's reliabil-
ity and validity and to compare CSDD results in Greek
depressive patients referred to a neuropsychiatry clinic
with and without AD Setting: University outpatient clinic
Methods: The Hellenic translations of the CSDD, and
HDRS were compared in evaluating 40 consecutive refer-
rals of patients with AD and 40 patients with major
depression without AD.
Results
The Hellenic CSDD translated demonstrated a high
degree of reliability, and of concurrent validity when com-
pared to the HDRS.
Discussion
These results indicate that the Hellenic version of the
CSDD is a reliable instrument, which is able to detect
depression in AD patients and to asses differences in clin-
ically referred groups of AD patients with depression and
patients with depression without AD.
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